Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus
Type1 Diabetes MellitusTrialNetDiabetes MellitusDiabetes Mellitus, Type 1Hydroxychloroquine
Lead Scientist at UCSF
- Stephen Gitelman
I am involved in a variety of different translational and clinical research projects, most related to diabetes. A number of the on-going studies are attempts to alter the course of autoimmune-mediated type 1 diabetes, often via immunomodulation, in order to preserve endogenous beta cell function. Some of the recent and on-going projects are described below.